Production (Stage)
BioLife Solutions, Inc.
BLFS
$21.78
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -103.60% | 831.59% | 92.52% | -122.83% | 31.66% |
| Total Depreciation and Amortization | 194.41% | -163.27% | -5.20% | 7.29% | 199.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 144.62% | -288.56% | -77.59% | 295.46% | -56.95% |
| Change in Net Operating Assets | -538.97% | 170.02% | -146.38% | 200.00% | -149.20% |
| Cash from Operations | 4.98% | -65.74% | -25.65% | 244.34% | -293.64% |
| Capital Expenditure | 47.01% | 48.19% | -288.78% | 200.00% | 65.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -135.94% | 56,069.17% | 99.07% | -2,479.80% | -90.55% |
| Cash from Investing | -136.91% | 4,480.55% | 87.49% | -5,979.19% | -105.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 27.03% | -26.23% | -1,226.14% | 200.00% | -230.27% |
| Issuance of Common Stock | -- | 41.30% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.14% | -144.56% | 272.17% | -32.91% | 1.93% |
| Cash from Financing | 26.77% | -292.51% | -47.87% | 26.05% | -109.67% |
| Foreign Exchange rate Adjustments | -- | -19.44% | -- | 100.00% | -203.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -139.93% | 3,266.02% | 127.55% | -34.43% | -135.33% |